Zhe Li

4.9k total citations · 1 hit paper
121 papers, 2.6k citations indexed

About

Zhe Li is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Zhe Li has authored 121 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 24 papers in Organic Chemistry and 17 papers in Pharmacology. Recurrent topics in Zhe Li's work include Phosphodiesterase function and regulation (28 papers), Cholinesterase and Neurodegenerative Diseases (16 papers) and Computational Drug Discovery Methods (14 papers). Zhe Li is often cited by papers focused on Phosphodiesterase function and regulation (28 papers), Cholinesterase and Neurodegenerative Diseases (16 papers) and Computational Drug Discovery Methods (14 papers). Zhe Li collaborates with scholars based in China, United States and Japan. Zhe Li's co-authors include Hai‐Bin Luo, Yinuo Wu, Yi‐You Huang, Deyan Wu, Peter Maitz, Michael Müller, Peiqing Liu, Yongxian Shao, Runduo Liu and Chang‐Guo Zhan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Zhe Li

114 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

2025 18 citations Zhe Li et al. profile →

Peers

Countries citing papers authored by Zhe Li

Since Specialization

Citations

This map shows the geographic impact of Zhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Li more than expected).

Fields of papers citing papers by Zhe Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Li. The network helps show where Zhe Li may publish in the future.

Co-authorship network of co-authors of Zhe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Li. A scholar is included among the top collaborators of Zhe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Li. Zhe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of novel azetidine-based imidazopyridines as selective and orally bioavailable inhibitors of phosphodiesterase 10A for the treatment of pulmonary arterial hypertension 2025 ·European Journal of Medicinal Chemistry ·(unknown), Hongxiang Xue, (unknown), Yuan Han, (unknown), Runduo Liu, Yi Yang, Quan Wang, Zhe Li, Tengteng Liu, Yi‐You Huang, Wei Dai, Hai‐Bin Luo, (unknown), (unknown), Lei Guo	0
2	Precision-Oriented Theophylline-Platinum(IV) Prodrugs: Eliciting Synthetic Lethality in BRCA1-Deficient Ovarian Cancer with Enhanced Efficacy and Reduced Toxicity In Vitro and In Vivo 2025 ·Journal of Medicinal Chemistry ·Xiaomeng Liu, (unknown), Qingtian Li, Zhe Li, Rui Rong, Cheng‐Zhi Xie, Xin Qiao, Yukuan Feng, Jing‐Yuan Xu	0
3	Gut Microbiome and Atherosclerosis: A Mendelian Randomization Study 2024 ·Reviews in Cardiovascular Medicine ·Yue Li, Yunxian Chen, Zhe Li, Yanrong Li, Yicai Chen, (unknown)	1
4	Improving protein-protein interaction prediction using protein language model and protein network features 2024 ·Analytical Biochemistry ·(unknown), Zhe Li, B. Dharma Rao, Maha A. Thafar, Muhammad Arif	15
5	HO-1 impairs the efficacy of radiotherapy by redistributing cGAS and STING in tumors 2024 ·Journal of Clinical Investigation ·(unknown), Zhaoqun Deng, (unknown), Cong Ding, Zhe Li, Zhimin Xu, Weipeng Chen, (unknown), Hairong Wei, Tingting He, (unknown), Jun Ma, Xu Cheng, (unknown)	7
6	Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination 2024 ·Immunity ·Zhe Li, Anna Obraztsova, Fuwei Shang, (unknown), (unknown), Katrin Busch, Monique van Straaten, C. Erec Stebbins, Rajagopal Murugan, Hedda Wardemann	4
7	Fast and versatile sequence-independent protein docking for nanomaterials design using RPXDock 2023 ·PLoS Computational Biology ·William Sheffler, (unknown), Quinton M. Dowling, Yang Hsia, Chelsea N. Fries, (unknown), (unknown), (unknown), Zhe Li, (unknown), Andrew J. Borst, Alena Khmelinskaia, Neil P. King, David Baker	16
8	Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma 2023 ·Annals of Translational Medicine ·Zhe Li, (unknown), Xinchang Lu, Yan Zhang, (unknown), (unknown), Yongkui Liu, Xiaoting Liu, Jiazhen Li	5
9	CircRNA: A new class of targets for gastric cancer drug resistance therapy 2023 ·Pathology & Oncology Research ·Ying Zheng, Zhe Li, Yao Wang, (unknown), Yifan Lin, Junming Guo, Guoliang Ye	17
10	Loss of the adaptor protein Sh3bgrl initiates ovarian fibrosis in zebrafish 2023 ·FEBS Letters ·(unknown), Dongxia Wang, (unknown), Bo Wu, Zhe Li, Xiaoling Guo, Haihe Wang, Shulan Yang	1
11	An automatic reduction method of 3D bone fragments based on a novel section contour point descriptor 2023 ·International Journal for Numerical Methods in Biomedical Engineering ·Song Zhang, (unknown), Qiming Cao, Zhe Li, (unknown), Bin Liu	0
12	Computer simulation and design of DNA-nanoprobe for fluorescence imaging DNA repair enzyme in living cells 2022 ·Biosensors and Bioelectronics ·Tian Cheng, (unknown), Chunyi Wang, (unknown), (unknown), Zhe Li, Runduo Liu, Yan Ma, (unknown), Jiewei Deng, Junqiu Zhai	20
13	Free energy perturbation (FEP)-guided scaffold hopping 2021 ·Acta Pharmaceutica Sinica B ·Deyan Wu, Xuehua Zheng, Runduo Liu, Zhe Li, (unknown), Qian Zhou, Yue Huang, (unknown), Chen Zhang, Yi‐You Huang, Hai‐Bin Luo	20
14	The roles of chemokine (C-X-C motif) ligand 13 in spinal cord ischemia-reperfusion injury in rats 2019 ·Brain Research ·Fengshou Chen, Xiaoqian Li, Zhe Li, Yongjian Zhou, (unknown), Hong Ma	18
15	The humanin peptide mediates ELP nanoassembly and protects human retinal pigment epithelial cells from oxidative stress 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Zhe Li, Parameswaran G. Sreekumar, (unknown), David R. Hinton, Ram Kannan, J. Andrew MacKay	19
16	Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds 2014 ·Molecular BioSystems ·Zhe Li, Xiao Lu, (unknown), Ying Gu, Xingshu Li, Yinuo Wu, Hai‐Bin Luo	18
17	Biochemical Mechanism of HIV-1 Resistance to Rilpivirine 2012 ·Journal of Biological Chemistry ·Kamalendra Singh, Bruno Marchand, K. Devendra, Bechan Sharma, Eleftherios Michailidis, Emily Ryan, (unknown), Maxwell D. Leslie, (unknown), Zhe Li, Pieter R. Norden, Atsuko Hachiya, Michael A. Parniak, Hongtao Xu, Mark A. Wainberg, Stefan G. Sarafianos	55
18	Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis 2009 ·Proceedings of the National Academy of Sciences ·Zhe Li, Hui Huang, Patricia Boland, Melissa G. Dominguez, Patricia Burfeind, Ka‐Man Venus Lai, (unknown), Nicholas W. Gale, Christopher Daly, Wojtek Auerbach, David M. Valenzuela, George D. Yancopoulos, Gavin Thurston	28
19	Mutagenesis of the Runt Domain Defines Two Energetic Hot Spots for Heterodimerization with the Core Binding Factor β Subunit 2003 ·Journal of Biological Chemistry ·Lina Zhang, Zhe Li, Jiangli Yan, Padmanava Pradhan, Takeshi Corpora, Matthew D. Cheney, Jerónimo Bravo, Alan J. Warren, John H. Bushweller, Nancy A. Speck	24
20	The effect of enterohemorrhagic Escherichia coli 0157:H7 on intestinal structure and solute transport in rabbits 1993 ·Gastroenterology ·Zhe Li, Cameron Bell, André G. Buret, Roy M. Robins‐Browne, Daniel Stiel, Edward V. O’Loughlin	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact